HLA gene polymorphism is a modifier of age-related breast cancer penetrance in carriers of BRCA1 pathogenic alleles
Preprint
- 31 January 2024
- preprint
- Published by Springer Nature in Research Square
Abstract
Purpose Female carriers of germline BRCA1 mutations almost invariably develop breast cancer (BC) however the age at onset is a subject of variation. We hypothesized that the age-related penetrance of BRCA1 mutations may depend on inherited variability in the host immune system. Methods Next-generation sequencing was utilized for genotyping of HLA class I/II genes (HLA-A, HLA-B, HLA-C, HLA-DPB1, HLA-DQB1 and HLA-DRB1/3/4/5) in patients with BRCA1-associated BC with early (/= 58 years, n = 108) age at onset. Results HLA-DQB1*06:03P prevalence was higher in the late-onset group due to the excess of allele carriers [25/108 (23.1%) vs. 22/215 (10.2%); OR 2.96, p < 0.001]. For all HLA-I loci, there was a trend towards an increase in the number of homozygotes in the early-onset group. This trend reached statistical significance for the HLA-A [14.4% vs. 6.5%, p = 0.037; OR 2.4, p = 0.042]. The frequencies of HLA-DPB1, HLA-DQB1 and HLA-DRB1/3/4/5 homozygous genotypes did not differ between young-onset and late-onset patients. The maximum degree of homozygosity detected in this study was 6 out of 7 HLA class I/II loci; all six carriers of these genotypes were diagnosed with BC at the age </= 38 years [OR = 6.97, p = 0.187]. Conclusion HLA polymorphism may play a role in modifying the penetrance of BRCA1 pathogenic variants. Certain HLA alleles or HLA homozygosity may modify the risk of BC in BRCA1 carriers.Keywords
All Related Versions
This publication has 45 references indexed in Scilit:
- Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACEJNCI: Journal of the National Cancer Institute, 2013
- Association between HLA‐DQA1, HLA‐DQB1 and oral cancerThe Kaohsiung Journal of Medical Sciences, 2011
- COMPUTATIONAL PREDICTION OF MHC II-ANTIGEN BINDING SUPPORTS DIVERGENT ALLELE ADVANTAGE AND EXPLAINS TRANS-SPECIES POLYMORPHISMEvolution, 2011
- MHC loci affecting cervical cancer risk: distinguishing the effects of HLA-DQB1 and non-HLA genes TNF, LTA, TAP1 and TAP2Genes & Immunity, 2008
- HLA class I supertypes: a revised and updated classificationBMC Immunology, 2008
- Analysis of HLA class I–II haplotype frequency and segregation in a cohort of patients with advanced stage ovarian cancerTissue Antigens, 2007
- Population BRCA1 and BRCA2 Mutation Frequencies and Cancer Penetrances: A Kin–Cohort Study in Ontario, CanadaJNCI: Journal of the National Cancer Institute, 2006
- Regulation of MHC class II gene expression by the class II transactivatorNature Reviews Immunology, 2005
- HLA-DQB1 and cervical cancer in Venezuelan womenGynecologic Oncology, 2005
- The DNA sequence and analysis of human chromosome 6Nature, 2003